Healthcare - Biotechnology - NASDAQ - US
$ 3.16
-12.2 %
$ 206 M
Market Cap
-8.1
P/E
BALANCE SHEET
101 M
ASSETS
21.3 M
LIABILITIES
59.3 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Zura Bio Limited
| Current Assets | 101 M |
| Cash & Short-Term Investments | 99.8 M |
| Receivables | 0 |
| Other Current Assets | 1.04 M |
| Non-Current Assets | 0 |
| Long-Term Investments | 0 |
| PP&E | 0 |
| Other Non-Current Assets | 0 |
| Current Liabilities | 20.3 M |
| Accounts Payable | 2.75 M |
| Short-Term Debt | 0 |
| Other Current Liabilities | 17.6 M |
| Non-Current Liabilities | 990 K |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 990 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Mar-2022 | |
|---|---|---|---|
| ASSETS | |||
| Cash & Cash Equivalents | 99.8 | 13.8 K | 4.7 |
| Short Term Investments | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 |
| Other Current Assets | 1.0 | 0.2 | 0 |
| Total Current Assets | 100.8 | 33.5 K | 4.7 |
| PP&E | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 139.4 |
| Other Long Term Assets | 0 | 141.5 | 0 |
| Other Assets | 0 | 0 | (139.4) |
| Total Assets | 100.8 | 141.5 | 4.7 |
| LIABILITIES | |||
| Accounts Payable | 2.7 | 2.0 | 0 |
| Short Term Debt | 0 | 0.4 | 0 |
| Other Current Liabilities | 17.6 | 12.5 | 39 K |
| Total Current Liabilities | 20.3 | 14.8 | 39 K |
| Long Term Debt | 0 | 12.5 | 0 |
| Deferred Tax Income | 0 | 0 | 0 |
| Other Liabilities | 1.0 | 0 | 12.5 |
| Total Liabilities | 21.3 | 14.8 | 39 K |
| EQUITY | |||
| Common Stock | 4 K | 141.4 | 139.4 |
| Retained Earnings | (103.5) | (32.1) | (7.8) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | (278.8) |
| Total Equity | 79.6 | (22.1) | 4.7 |
| Total Liabilities and Equity | 100.8 | 5.3 | 4.7 |
| SHARES OUTSTANDING | |||
| Common Shares Outstanding | 33.1 | 17.2 | 17.2 |